Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH Injection in Prader-Willi Syndrome Children (Motor Development)
CTR20180797Phase 3Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Prader-Willi syndrome (PWS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started May 2018; status: completed.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on CTR20180797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180797.